Group One Trading’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04K Hold
600
– – ﹤0.01% 7139
2026
Q2
$1.19K Sell
600
-200
-25% -$289 ﹤0.01% 7146
2026
Q1
$1.02K Buy
+800
New +$1.5K ﹤0.01% 7212
2025
Q3
– Sell
-2,000
Closed -$7.54K – 8683
2025
Q2
$7.54K Hold
2,000
– – ﹤0.01% 6890
2025
Q1
$9.06K Buy
+2,000
New +$10.6K ﹤0.01% 6329
2024
Q2
– Sell
-2,200
Closed -$16.6K – 7032
2024
Q1
$16.6K Buy
+2,200
New +$20.1K ﹤0.01% 5561
2022
Q4
– Sell
-800
Closed -$8K – 7570
2022
Q3
$8K Buy
+800
New +$10.6K ﹤0.01% 6627
2022
Q1
– Sell
-100
Closed -$4K – 8278
2021
Q4
$4K Hold
100
– – ﹤0.01% 7699
2021
Q3
$5K Sell
100
-500
-83% -$27.3K ﹤0.01% 7732
2021
Q2
$33K Buy
600
+100
+20% +$5.33K ﹤0.01% 6893
2021
Q1
$23K Hold
500
– – ﹤0.01% 6701
2020
Q4
$22K Buy
500
+300
+150% +$11.1K ﹤0.01% 5466
2020
Q3
$7K Hold
200
– – ﹤0.01% 5532
2020
Q2
$6K Buy
+200
New +$5.53K ﹤0.01% 5307

Other funds holding HCAT

Group One Trading's HCAT Position: Q3 2026 in Review

Group One Trading held its Health Catalyst (HCAT) position steady in Q3 2026 at 190 shares worth $329. The position accounts for ﹤0.01% of the portfolio, ranked #7303.

Group One Trading first reported a position in HCAT in Q1 2020 and has held it in 11 quarters since. The position peaked at $116K in Q3 2022. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Group One Trading held 190 shares of Health Catalyst worth $329 as of Q3 2026.
  • Group One Trading left its Health Catalyst share count unchanged in Q3 2026.
  • Health Catalyst made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7303 holding.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and has held it in 11 quarters since.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.